A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases
RemeGen Co., Ltd.
RemeGen Co., Ltd.
RenJi Hospital
TaiHao Medical Inc.
Maastricht University Medical Center
European Institute of Oncology
IRCCS San Raffaele
Instituto de Investigación Hospital Universitario La Paz
Centro di Riferimento Oncologico - Aviano
Sun Yat-sen University
KK Women's and Children's Hospital
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
ChineseAMS
Zhejiang Cancer Hospital
Peking Union Medical College Hospital
Zhejiang Cancer Hospital
King's College London
University of British Columbia
Women's College Hospital
Sysmex America, Inc.
National Taiwan University Hospital